Open-Label Safety Study of AXS-05 in Subjects With TRD
Status:
Enrolling by invitation
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
This study is a multi-center, open-label trial to evaluate the long-term safety and efficacy
of AXS-05 in subjects with treatment resistant depression (TRD).